Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
Was to evaluate the safety, tolerability and efficacy of multiple doses of canakinumab
(ACZ885) vs. placebo when administered via intravenous infusion (IV), on pulmonary function
in patients with COPD